Research analysts at Royal Bank of Canada assumed coverage on shares of Udg Healthcare (LON:UDG) in a research note issued to investors on Wednesday. The brokerage set an “outperform” rating and a GBX 800 ($10.45) price target on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 18.34% from the company’s current price.
Several other analysts also recently weighed in on UDG. Peel Hunt reissued a “buy” rating on shares of Udg Healthcare in a research report on Wednesday, August 1st. Liberum Capital reissued a “buy” rating and set a GBX 884 ($11.55) target price on shares of Udg Healthcare in a research report on Wednesday, August 8th. Numis Securities reissued a “reduce” rating on shares of Udg Healthcare in a research report on Wednesday, August 8th. Jefferies Financial Group raised shares of Udg Healthcare to a “buy” rating and dropped their target price for the stock from GBX 895 ($11.69) to GBX 890 ($11.63) in a research report on Thursday, August 9th. Finally, Barclays reissued an “equal weight” rating on shares of Udg Healthcare in a research report on Friday, September 28th. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the stock. Udg Healthcare currently has a consensus rating of “Hold” and a consensus price target of GBX 845.60 ($11.05).
LON:UDG opened at GBX 676 ($8.83) on Wednesday. Udg Healthcare has a twelve month low of GBX 690 ($9.02) and a twelve month high of GBX 963 ($12.58).
Udg Healthcare Company Profile
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates through three segments: Ashfield, Sharp, and Aquilant.
Featured Article: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.